CP
CPBLF.US ALS Limited
- Market cap
- USD 8.24B
- P/E
- 34.3x
- P/B
- 6.27x
- ROE
- 18.7%
- Dividend yield
- 2.00%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Mar 2026.
Is CPBLF.US undervalued?
Graham numberThe Graham number of ALS Limited cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ALS Limited fundamental analysis
No fundamental analysis for ALS Limited yet.
ALS Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ALS Limited
ALS Limited engages in the provision of professional technical services and analytical services primarily in the areas of testing, measurement, and inspection in Africa, Asia Pacific, Europe, the Middle East, North Africa, and the United States. It operates in two segments: Commodities and Life Sciences. The Commodities segment offers assaying and analytical testing, and metallurgical services for mining and mineral exploration companies. Its testing and consulting services …
Full company profileALS Limited financial statements
ALS Limited annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 1.27B | 1.45B | 1.66B | 1.83B | 1.76B | 2.11B | 2.28B | 2.46B | 3.00B | 3.33B |
| Gross Profit | 1.14B | 1.29B | 1.48B | 1.64B | 1.58B | 1.88B | 2.03B | 2.19B | 2.69B | 1.04B |
| Operating Income | 171M | 209M | 257M | 277M | 266M | 318M | 620M | 402M | 425M | 584M |
| EBITDA | 237M | 216M | 339M | 320M | 416M | 515M | 586M | 357M | 694M | 838M |
| Net Income | 81.6M | 51.8M | 154M | 76.3M | 170M | 191M | 291M | 12.9M | 256M | 319M |
| EPS | 0.16 | 0.10 | 0.31 | 0.16 | 0.35 | 0.39 | 0.60 | 0.03 | 0.53 | 0.63 |
| Balance Sheet | ||||||||||
| Total Assets | 2.15B | 2.06B | 2.18B | 2.93B | 2.48B | 2.84B | 3.33B | 3.70B | 4.06B | 3.98B |
| Total Liabilities | 964M | 936M | 1.08B | 1.82B | 1.40B | 1.71B | 1.95B | 2.50B | 2.77B | 2.27B |
| Shareholders' Equity | 1.18B | 1.11B | 1.09B | 1.10B | 1.07B | 1.12B | 1.37B | 1.18B | 1.28B | 1.70B |
| Cash & Short-term Investments | 249M | 188M | 148M | 424M | 169M | 123M | 180M | 300M | 268M | 150M |
| Total Debt | 742M | 696M | 780M | 1.45B | 968M | 1.24B | 1.45B | 1.87B | 2.09B | 1.57B |
| Cash Flow | ||||||||||
| Operating Cash Flow | 175M | 186M | 221M | 259M | 266M | 287M | 440M | 350M | 410M | 495M |
| Capital Expenditure | 58.7M | 73.4M | 109M | 121M | 81.1M | 119M | 146M | 152M | 165M | 263M |
| Free Cash Flow | 117M | 112M | 112M | -121M | -81.1M | -119M | -146M | 198M | 245M | 232M |
| Ratios | ||||||||||
| ROE | 6.9% | 4.7% | 14.1% | 6.9% | 15.9% | 17.0% | 21.3% | 1.1% | 20.0% | 18.7% |
| ROA | 3.8% | 2.5% | 7.1% | 2.6% | 6.8% | 6.7% | 8.7% | 0.3% | 6.3% | 8.0% |
| Net Profit Margin | 6.4% | 3.6% | 9.2% | 4.2% | 9.6% | 9.0% | 12.8% | 0.5% | 8.5% | 9.6% |
| Debt to Equity | 0.63x | 0.63x | 0.71x | 1.32x | 0.91x | 1.10x | 1.06x | 1.58x | 1.64x | 0.92x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
ALS Limited dividends
- Dividend yield
- 2.00%
- Forward dividend
- 0.29 USD
- Payout ratio
- 60.7%
- Ex-dividend date
- Jun 12, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | AUD 194M | 0.38 | 60.7% |
| 2025 | AUD 177M | 0.36 | 69.1% |
| 2024 | AUD 189M | 0.39 | 1,463.6% |
| 2023 | AUD 177M | 0.36 | 60.6% |
| 2022 | USD 131M | 0.27 | 68.9% |
| 2021 | USD 71.3M | 0.15 | 42.0% |
| 2020 | USD 112M | 0.23 | 146.8% |
| 2019 | USD 98.0M | 0.20 | 63.7% |
| 2018 | USD 80.8M | 0.16 | 156.0% |
| 2017 | USD 58.0M | 0.11 | 71.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1061:1000 on Nov 30, 2015.
Who owns ALS Limited
- Insiders 2.45%
- Institutions 50.57%
- Public & others 46.98%
- Shares outstanding 508M
- Free float 493M
ALS Limited company profile
- Company name
- ALS Limited
- Ticker
- CPBLF.US
- Exchange
- USA Stocks
- Sector
- Industrials
- Industry
- Professional Services
- Employees
- 23,342
- Fiscal year end
- March
- Address
- 25 King Street, Brisbane, QLD, Australia, 4006
- Phone
- 61 7 3367 7900
- Website
- alsglobal.com
About ALS Limited
ALS Limited engages in the provision of professional technical services and analytical services primarily in the areas of testing, measurement, and inspection in Africa, Asia Pacific, Europe, the Middle East, North Africa, and the United States. It operates in two segments: Commodities and Life Sciences. The Commodities segment offers assaying and analytical testing, and metallurgical services for mining and mineral exploration companies. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. This segment also provides the coal industry, such as sampling, analysis and certification, formation evaluation services, tribology testing services, and related analytical testing. The Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets; and microbiological, physical, and chemical testing services. This segment provides analytical testing data to assist consulting and engineering firms, industries, and governments. ALS Limited was founded in 1863 and is headquartered in Brisbane, Australia.
ALS Limited management
6- Mr. Malcolm DeaneCEO, MD & Director · born 1984
- Mr. Stuart G. Hutton BBus, C.A.Chief Financial Officer · born 1968
- Ms. Dayna Field B.Com., L.L.B.General Counsel & Company Secretary
- Mr. Michael Burcham B Sc, Grad Cert RM, Grad Dip App, GradDip Env, MRAChief Risk Officer
- Ms. Heike TruolChief Strategy Officer · born 1970
- Mr. Greg Affleck CPAGroup Financial Controller